Assessment of the Immune Response to Tumor Cell Apoptosis and Efferocytosis

传出细胞增多 细胞毒性T细胞 细胞凋亡 癌症研究 免疫系统 免疫学 医学 梅尔特克 肿瘤微环境 生物 巨噬细胞 受体 内科学 受体酪氨酸激酶 体外 生物化学
作者
Thomas A. Werfel
出处
期刊:Methods in molecular biology [Springer Science+Business Media]
卷期号:2543: 45-55 被引量:4
标识
DOI:10.1007/978-1-0716-2553-8_5
摘要

Apoptotic cells are cleared from the body principally through recognition and engulfment by neighboring phagocytes, a process known as efferocytosis. During efferocytosis, phagocytes are recruited to the site/activated by "find me" signals released from apoptotic cells, precisely identify apoptotic cells by the recognition of "eat me" signals on the apoptotic cell surface, and engulf the apoptotic cells to prevent secondary necrosis and inflammation. Thus, efferocytosis is critical for tissue homeostasis in normal physiology. However, efferocytosis of apoptotic tumor cells-performed by tumor-associated macrophages-suppresses immunity within the tumor microenvironment and limits the antitumor response. This phenomenon is further exacerbated in tumor residual disease because of the high apoptotic cell burden generated by cytotoxic therapies. Blocking efferocytosis could be a powerful approach to boost tumor immunogenicity, particularly as a combination approach with cytotoxic therapies that produce many apoptotic cells, but little is currently known about the immune response to efferocytosis. Moreover, there is a dearth of in vivo models available to study the immunologic and therapeutic consequences of blocking efferocytosis in tumor residual disease.Here, we describe a model that enables in vivo studies of tumor immunology in the aftermath of cytotoxic therapy with an emphasis on the impact of efferocytosis. Orthotopic HER2+ mammary tumors are established in immune-competent mice, followed by a single administration of lapatinib, a receptor tyrosine kinase inhibitor of HER2, to the mice that induces widespread, transient apoptosis in the tumor microenvironment. In the days following lapatinib treatment, agents that block efferocytosis such as BMS-777607 are administered. Tissue is collected from cohorts of mice at day 2 (after lapatinib treatment only) to assess apoptosis, day 8 (after lapatinib treatment followed by blockade of efferocytosis) to assess the immune response to apoptosis and efferocytosis, and day 28 (after 4 consecutive weeks of treatment) to assess therapeutic efficacy. This model enables mechanistic studies of tumor immunology in residual disease as well as therapeutic efficacy studies of targeted agents that disrupt efferocytosis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
梦梦完成签到,获得积分10
1秒前
1秒前
licheng完成签到,获得积分10
2秒前
he大海贼完成签到,获得积分10
2秒前
疯了半天完成签到,获得积分10
2秒前
2秒前
阿飞发布了新的文献求助10
3秒前
xiaoni完成签到,获得积分10
3秒前
3秒前
hua完成签到,获得积分10
3秒前
周航完成签到,获得积分10
3秒前
我要的飞翔完成签到,获得积分10
3秒前
独特聪展完成签到 ,获得积分10
3秒前
4秒前
科科完成签到,获得积分10
4秒前
transhuman完成签到,获得积分10
4秒前
4秒前
爱笑白卉完成签到,获得积分10
5秒前
小伙子完成签到,获得积分0
5秒前
KDX完成签到,获得积分10
6秒前
6秒前
隐形曼青的应助被搞怪的老九采纳,获得30
6秒前
6秒前
愿景完成签到,获得积分10
7秒前
熹微发布了新的文献求助10
7秒前
元元完成签到 ,获得积分10
7秒前
拼搏凝冬发布了新的文献求助10
7秒前
火土关注了科研通微信公众号
7秒前
完美世界的应助被顺利曼易采纳,获得10
8秒前
seed85完成签到,获得积分10
8秒前
无极微光的应助被eee采纳,获得20
8秒前
方羽发布了新的文献求助10
8秒前
meng完成签到,获得积分10
8秒前
Yy完成签到,获得积分10
8秒前
虚拟的冰凡完成签到,获得积分10
8秒前
8秒前
天真小甜瓜完成签到,获得积分10
8秒前
LLLTB关注了科研通微信公众号
9秒前
不摇碧莲完成签到,获得积分10
9秒前
杨晓兰完成签到,获得积分10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180586
求助须知:如何正确求助?哪些是违规求助? 9570581
关于积分的说明 21813457
捐赠科研通 7776777
什么是DOI,文献DOI怎么找? 3433294
关于科研通互助平台的介绍 2557547
邀请新用户注册赠送积分活动 2479253